Boston Scientific Corp. (BSX) Financials Nov 20, 2
Post# of 250601
Posted On: 11/21/2014 4:59:38 AM
Boston Scientific Corp. (BSX) Financials Nov 20, 2014, 7:25 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Boston Scientific Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 8.19B 7.81B 7.62B 7.25B 7.14B
Cost of Goods Sold (COGS) incl. D&A 3.05B 3.03B 2.95B 2.7B 2.62B
COGS excluding D&A 2.21B 2.22B 2.23B 2.01B 1.93B
Depreciation & Amortization Expense 834M 816M 717M 683M 689M
Depreciation 323M 303M 296M 288M 279M
Amortization of Intangibles 511M 513M 421M 395M 410M
Gross Income 5.14B 4.77B 4.67B 4.55B 4.52B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.65B 3.51B 3.38B 3.41B 3.48B
Research & Development 1.03B 939M 895M 886M 861M
Other SG&A 2.62B 2.58B 2.48B 2.52B 2.62B
Other Operating Expense 191M 185M 172M 153M 140M
Unusual Expense 2.18B 1.7B 890M 4.82B 830M
EBIT after Unusual Expense (2.18B) (1.7B) (890M) (4.82B) (830M)
Non Operating Income/Expense (66M) (54M) 684M (28M) (43M)
Non-Operating Interest Income 7M 13M 7M 5M 6M
Equity in Affiliates (Pretax) - - - - (2M)
Interest Expense 366M 396M 282M 263M 255M
Gross Interest Expense 366M 396M 282M 263M 255M
Interest Capitalized 0 0 0 0 0
Pretax Income (1.31B) (1.06B) 642M (4.11B) (223M)
Income Tax (283M) 2M 201M (39M) (102M)
Income Tax - Current Domestic (191M) (74M) 53M 33M 37M
Income Tax - Current Foreign (2M) 125M 91M 139M 105M
Income Tax - Deferred Domestic (130M) (29M) 78M (211M) (229M)
Income Tax - Deferred Foreign 40M (20M) (21M) 0 (15M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.03B) (1.07B) 441M (4.07B) (121M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.03B) (1.07B) 441M (4.07B) (121M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.03B) (1.07B) 441M (4.07B) (121M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.03B) (1.07B) 441M (4.07B) (121M)
EPS (Basic) (0.68) (0.70) 0.29 (2.89) (0.09)
Basic Shares Outstanding 1.51B 1.52B 1.51B 1.41B 1.34B
EPS (Diluted) (0.68) (0.70) 0.29 (2.89) (0.09)
Diluted Shares Outstanding 1.51B 1.52B 1.52B 1.41B 1.34B
EBITDA 2.13B 1.89B 1.84B 1.68B 1.59B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Boston Scientific Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 8.19B 7.81B 7.62B 7.25B 7.14B
Cost of Goods Sold (COGS) incl. D&A 3.05B 3.03B 2.95B 2.7B 2.62B
COGS excluding D&A 2.21B 2.22B 2.23B 2.01B 1.93B
Depreciation & Amortization Expense 834M 816M 717M 683M 689M
Depreciation 323M 303M 296M 288M 279M
Amortization of Intangibles 511M 513M 421M 395M 410M
Gross Income 5.14B 4.77B 4.67B 4.55B 4.52B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.65B 3.51B 3.38B 3.41B 3.48B
Research & Development 1.03B 939M 895M 886M 861M
Other SG&A 2.62B 2.58B 2.48B 2.52B 2.62B
Other Operating Expense 191M 185M 172M 153M 140M
Unusual Expense 2.18B 1.7B 890M 4.82B 830M
EBIT after Unusual Expense (2.18B) (1.7B) (890M) (4.82B) (830M)
Non Operating Income/Expense (66M) (54M) 684M (28M) (43M)
Non-Operating Interest Income 7M 13M 7M 5M 6M
Equity in Affiliates (Pretax) - - - - (2M)
Interest Expense 366M 396M 282M 263M 255M
Gross Interest Expense 366M 396M 282M 263M 255M
Interest Capitalized 0 0 0 0 0
Pretax Income (1.31B) (1.06B) 642M (4.11B) (223M)
Income Tax (283M) 2M 201M (39M) (102M)
Income Tax - Current Domestic (191M) (74M) 53M 33M 37M
Income Tax - Current Foreign (2M) 125M 91M 139M 105M
Income Tax - Deferred Domestic (130M) (29M) 78M (211M) (229M)
Income Tax - Deferred Foreign 40M (20M) (21M) 0 (15M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.03B) (1.07B) 441M (4.07B) (121M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.03B) (1.07B) 441M (4.07B) (121M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.03B) (1.07B) 441M (4.07B) (121M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.03B) (1.07B) 441M (4.07B) (121M)
EPS (Basic) (0.68) (0.70) 0.29 (2.89) (0.09)
Basic Shares Outstanding 1.51B 1.52B 1.51B 1.41B 1.34B
EPS (Diluted) (0.68) (0.70) 0.29 (2.89) (0.09)
Diluted Shares Outstanding 1.51B 1.52B 1.52B 1.41B 1.34B
EBITDA 2.13B 1.89B 1.84B 1.68B 1.59B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼